JINXIN FERT.GRP HD-,00001

JINXIN FERT.GRP HD-,00001

Share · KYG5140J1013 · A2PL6U (XHKG)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of JINXIN FERT.GRP HD-,00001
No Price
29.04.2026 05:27
Current Prices from JINXIN FERT.GRP HD-,00001
ExchangeTickerCurrencyLast TradePriceDaily Change
XDQU: Quotrix
Quotrix
JFGLRS13.DUSD
EUR
29.04.2026 05:27
0,26 EUR
-
OTC: UTC
UTC
JXFGF
USD
28.04.2026 20:00
0,29 USD
0,00 USD
XDUS: Düsseldorf
Düsseldorf
JFGLRS13.DUSB
EUR
28.04.2026 17:30
0,25 EUR
-
Invested Funds

The following funds have invested in JINXIN FERT.GRP HD-,00001:

Fund
iShares MSCI EM SRI UCITS ETF USD (Acc)
Vol. in million
3.963,03
Percentage (%)
0,16 %
Fund
iShares MSCI EM SRI UCITS ETF USD (Dist)
Vol. in million
350,31
Percentage (%)
0,16 %
Fund
iShares MSCI EM Islamic UCITS ETF USD (Dist)
Vol. in million
109,24
Percentage (%)
0,10 %
Fund
iShares MSCI EM ESG Enhanced UCITS ETF USD (Acc)
Vol. in million
939,38
Percentage (%)
0,08 %
Fund
iShares MSCI EM ESG Enhanced UCITS ETF USD (Dist)
Vol. in million
223,07
Percentage (%)
0,08 %
Company Profile for JINXIN FERT.GRP HD-,00001 Share
Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.

Company Data

Name JINXIN FERT.GRP HD-,00001
Company Jinxin Fertility Group Limited
Website https://www.jxr-fertility.com
Primary Exchange XHKG HKEX
WKN A2PL6U
ISIN KYG5140J1013
Asset Class Share
Sector Healthcare
Industry Medical - Care Facilities
CEO Yang Dong
Market Capitalization 770 Mio
Country China
Currency EUR
Employees 3,2 T
Address No. 301, North Jingsha Road, Chengdu
IPO Date 2021-06-25
Dividends from 'JINXIN FERT.GRP HD-,00001'
Ex-Date Dividend per Share
02.07.2024 0,06 HKD
30.06.2022 0,009 USD
02.07.2020 0,07 HKD

Ticker Symbols

Name Symbol
Over The Counter JXFGF
Düsseldorf JFGLRS13.DUSB
Frankfurt 3NX.F
Quotrix JFGLRS13.DUSD
More Shares
Investors who hold JINXIN FERT.GRP HD-,00001 also have the following shares in their portfolio:
AMUNDI FUNDS EUROPEAN EQUITY CONSERVATIVE - M EUR (C)
AMUNDI FUNDS EUROPEAN EQUITY CONSERVATIVE - M EUR (C) ETF
DZ BANK IS.A1248
DZ BANK IS.A1248 Bond